Tier A: Venture CapitalVenture Capital
Medicxi
HQ
Geneva, Switzerland & London, UK
Founded
2016
AUM
$1B
Portfolio
3 companies
AI × Biotech Thesis
European biotech VC with selective AI platform exposure. Strong in biologics and platform companies.
Verified Investments
3 companies- Exscientia (exit, merged with Recursion 2024)
- Enterome
- Cellarity (co-investor)
· Dot indicates company has a profile page on biotech.today
Active Partners
2 on record- Francesco De RubertisCo-Founder & Partner
- Giles O'GradyPartner